Liver Diseases, Alcoholic clinical trials
The registry lists 74 studies for Liver Diseases, Alcoholic across more than 10 countries. 25 are recruiting or about to start. 44 of them are mainly about Liver Diseases, Alcoholic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 2 narrower conditions too, such as Hepatitis, Alcoholic: 208 studies, 56 open.
Get an email when these change. Save the Liver Diseases, Alcoholic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Lille (5) · Erasme University Hospital (4) · The Cleveland Clinic (4) · Chuncheon Sacred Heart Hospital (4) · University Hospital, Montpellier (3) · University of Pittsburgh (2) · Institute of Liver and Biliary Sciences, India (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2)
What is being tested here
Drugs under test in Liver Diseases, Alcoholic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7
- Nov 2026The Liver Care Trial · Zealand University Hospital
- Nov 2026Evaluating Alcohol Use in Alcoholic Liver Disease · Nicole T Shen
- Mar 2027Integrated Diagnostics for Early Diagnosis of Liver Disease · Manchester University NHS Foundation Trust
- Apr 2027Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease · University Hospital, Lille
- Aug 2027Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease · The Affiliated Hospital of Hangzhou Normal University
- Sep 2027Comparison of ALD, NASH, and Healthy Control Patients · The Cleveland Clinic
- Nov 2027A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease · GlaxoSmithKline
Who these studies take
Of the 18 Liver Diseases, Alcoholic studies recruiting now, 7 (39%) set no upper age limit and 7 (39%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (22%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 14 (78%) | 14 (78%) |
| 30 | 17 (94%) | 17 (94%) |
| 40 | 18 (100%) | 18 (100%) |
| 50 | 18 (100%) | 18 (100%) |
| 65 | 18 (100%) | 18 (100%) |
| 75 | 16 (89%) | 16 (89%) |
| 85 | 9 (50%) | 9 (50%) |
Across all 74 studies, recruiting or not: 42% stop at 75 or younger and 11% at 65; 5% take children; 0% are for women only and 3% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Started recruiting1
- Elastography-based Brief Alcohol Intervention in Hospitalized IndividualsOct 22, 2026NCT07637539
Newly registered1
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)Nov 12, 2026NCT07933328
Studies
Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 → or search them.
- A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseaseRecruitingNCT06613698Phase 219 countries
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD)Not yet recruitingNCT07933328Phase 2
- Ethanol Induces Skeletal Muscle AutophagyRecruitingNCT032097911 country
- A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)RecruitingNCT07791043Phase 24 countries
- Elastography-based Brief Alcohol Intervention in Hospitalized IndividualsRecruitingNCT07637539Not applicable1 country
- Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19RecruitingNCT04858412Not applicable1 country
- Comparison of ALD, NASH, and Healthy Control PatientsRecruitingNCT032249491 country
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic PatientsRecruitingNCT05699018Not applicable1 country
- Study of Alcohol-related Liver Disease in EuropeRecruitingNCT044006041 country
- Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver DiseaseRecruitingNCT041065181 country
- Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver DiseaseNot yet recruitingNCT07399600Not applicable1 country
- Intra-Hepatic Microbiota in Alcoholic HepatitisRecruitingNCT063079641 country
- Integrated Diagnostics for Early Diagnosis of Liver DiseaseRecruitingNCT046664021 country
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling by invitationNCT042341391 country
- Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled TrialRecruitingNCT06493773Not applicable1 country
- Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver CirrhosisRecruitingNCT071695261 country
- Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver DiseaseRecruitingNCT04320199Not applicable1 country
- Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)Not yet recruitingNCT069075634 countries
- MRG-001 in Patients With Alcoholic HepatitisNot yet recruitingNCT06307522Phase 2
- French National MICMAF CohortRecruitingNCT058958901 country
- The Liver Care TrialRecruitingNCT05855031Not applicable1 country
- Screening At-risk Populations for Hepatic Fibrosis With Non-invasive MarkersRecruitingNCT03308916Not applicable1 country
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT054733251 country
- Evaluating Alcohol Use in Alcoholic Liver DiseaseRecruitingNCT032670691 country
- Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver DiseaseNot yet recruitingNCT03503708Not applicable1 country
- CM for Patients With ALD After Liver TransplantCompletedNCT06304467Not applicable1 country
- Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)Active, not recruitingNCT031139291 country
- Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use DisordersCompletedNCT05375682Not applicable1 country
- BRIDGE Device for Post-operative Pain ControlTerminatedNCT03265249Not applicable1 country
- Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With PrednisoloneCompletedNCT02281929Phase 31 country
- Alcoholic Liver Disease and the Gut MicrobiomeActive, not recruitingNCT05007470Not applicable1 country
- Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver DiseaseCompletedNCT04736966Phase 11 country
- Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric UnitCompletedNCT05602870Not applicable1 country
- Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic MicrobiotaActive, not recruitingNCT03863730Not applicable1 country
- Integrated Approaches for Identifying Molecular Targets in Liver DiseaseCompletedNCT039150021 country
- DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03917407Phase 21 country
- Sulfation of Bile Acids as a Biomarker for Hepatobiliary DiseasesTerminatedNCT012000821 country
- Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.CompletedNCT01789008Not applicable1 country
- Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic HepatitisCompletedNCT05840640Phase 41 country
- Gut Mycobiome Profile in Alcoholic Liver Disease.Status unknownNCT057931901 country
- Early Detection of Alcoholic Liver DiseaseWithdrawnNCT04070508
- Integrated Stepped Care for Unhealthy Alcohol Use in HIVCompletedNCT01410123Not applicable1 country
- Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic CirrhosisTerminatedNCT035083881 country
- Alcohol, Gut Leakiness, & Liver DiseaseCompletedNCT05428072Early Phase 11 country
- Prognostic Factors After Liver TransplantationCompletedNCT05018741
- Impact of Integrating an Addiction Team on Post Liver Transplantation Survival for Alcohol-related Liver Disease and Its Complications.CompletedNCT049646871 country
- Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver DiseaseCompletedNCT012375741 country
- Cognitive Function of Alcoholic Compensated Liver CirrhosisCompletedNCT045577741 country
- Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase DeficiencyTerminatedNCT02193867Phase 24 countries
- S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver DiseaseStatus unknownNCT03938662Not applicable1 country